URANEX (Germany) Performance
| U1P Stock | EUR 0.02 0.00 0.00% |
The entity owns a Beta (Systematic Risk) of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and URANEX are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days URANEX has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, URANEX is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
URANEX |
URANEX Relative Risk vs. Return Landscape
If you would invest 2.48 in URANEX on November 7, 2025 and sell it today you would earn a total of 0.00 from holding URANEX or generate 0.0% return on investment over 90 days. URANEX is producing return of less than zero assuming 0.0% volatility of returns over the 90 days investment horizon. Simply put, 0% of all stocks have less volatile historical return distribution than URANEX, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
URANEX Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of URANEX for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for URANEX can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| URANEX generated a negative expected return over the last 90 days | |
| URANEX has some characteristics of a very speculative penny stock | |
| URANEX has high likelihood to experience some financial distress in the next 2 years |
URANEX Fundamentals Growth
URANEX Stock prices reflect investors' perceptions of the future prospects and financial health of URANEX, and URANEX fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on URANEX Stock performance.
| Current Valuation | 130.74 M | ||||
| Price To Book | 3.48 X | ||||
| Price To Sales | 1,000,000 X | ||||
| Total Debt | 8.24 M | ||||
| Total Asset | 1.86 M | ||||
| Retained Earnings | (270.41 M) | ||||
About URANEX Performance
By analyzing URANEX's fundamental ratios, stakeholders can gain valuable insights into URANEX's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if URANEX has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if URANEX has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about URANEX performance evaluation
Checking the ongoing alerts about URANEX for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for URANEX help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| URANEX generated a negative expected return over the last 90 days | |
| URANEX has some characteristics of a very speculative penny stock | |
| URANEX has high likelihood to experience some financial distress in the next 2 years |
- Analyzing URANEX's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether URANEX's stock is overvalued or undervalued compared to its peers.
- Examining URANEX's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating URANEX's management team can have a significant impact on its success or failure. Reviewing the track record and experience of URANEX's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of URANEX's stock. These opinions can provide insight into URANEX's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for URANEX Stock analysis
When running URANEX's price analysis, check to measure URANEX's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy URANEX is operating at the current time. Most of URANEX's value examination focuses on studying past and present price action to predict the probability of URANEX's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move URANEX's price. Additionally, you may evaluate how the addition of URANEX to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |